BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chin JL, O'Toole D. Diagnosis and Management of Upper Gastrointestinal Neuroendocrine Tumors. Clin Endosc. 2017;50:520-529. [PMID: 29207862 DOI: 10.5946/ce.2017.181] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Fernandes CJ, Leung G, Eads JR, Katona BW. Gastroenteropancreatic Neuroendocrine Tumors. Gastroenterology Clinics of North America 2022. [DOI: 10.1016/j.gtc.2022.06.002] [Reference Citation Analysis]
2 Canakis A, Lee LS. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Endosc 2022; 14(5): 267-290 [DOI: 10.4253/wjge.v14.i5.267] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yin F, Wu ZH, Lai JP. New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(17): 1751-1767 [DOI: 10.3748/wjg.v28.i17.1751] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Merola E, Michielan A, Rozzanigo U, Erini M, Sferrazza S, Marcucci S, Sartori C, Trentin C, de Pretis G, Chierichetti F. Therapeutic strategies for gastroenteropancreatic neuroendocrine neoplasms: State-of-the-art and future perspectives. World J Gastrointest Surg 2022; 14(2): 78-106 [DOI: 10.4240/wjgs.v14.i2.78] [Reference Citation Analysis]
5 Carvão J, Dinis-Ribeiro M, Pimentel-Nunes P, Libânio D. Neuroendocrine Tumors of the Gastrointestinal Tract: A Focused Review and Practical Approach for Gastroenterologists. GE Port J Gastroenterol 2021;28:336-48. [PMID: 34604465 DOI: 10.1159/000512089] [Reference Citation Analysis]
6 Do MY, Jang SI, Kang HP, Kim EJ, Lee KJ, Park GE, Lee SJ, Lee DK, Woo SM, Cho JH. Comparison of the Clinical Features and Outcomes of Gallbladder Neuroendocrine Carcinoma with Those of Adenocarcinoma: A Propensity Score-Matched Analysis. Cancers (Basel) 2021;13:4713. [PMID: 34572940 DOI: 10.3390/cancers13184713] [Reference Citation Analysis]
7 Odisho T, Shi D, Aburashed A. Successful endoscopic resection of an unusually enlarged and pedunculated type I gastric carcinoid tumour. BMJ Case Rep 2021;14:e244292. [PMID: 34413045 DOI: 10.1136/bcr-2021-244292] [Reference Citation Analysis]
8 Zhou YJ, Wang QW, Zhang QW, Chen JN, Wang XY, Gao YJ, Li XB. Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment. Front Endocrinol (Lausanne) 2021;12:658392. [PMID: 34122337 DOI: 10.3389/fendo.2021.658392] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Jung SW. Endoscopic Treatment of Gastric and Duodenal Neuroendocrine Tumors: Present and Future. Korean J Helicobacter Up Gastrointest Res 2021;21:29-34. [DOI: 10.7704/kjhugr.2020.0055] [Reference Citation Analysis]
10 Ragheb J, Mony S, Klapman J, Erim T, Reagan A, Butler R, Dong Y, Cruise M, Centeno BA, Bejarano P, Stevens T, Hayat U, Bhatt A. Impact of margin status on outcomes after endoscopic resection of well-differentiated duodenal neuroendocrine tumors. Gastrointest Endosc 2021;94:580-8. [PMID: 33676923 DOI: 10.1016/j.gie.2021.02.033] [Reference Citation Analysis]
11 Rosenbaum MW, Gonzalez RS. Targeted therapy for upper gastrointestinal tract cancer: current and future prospects. Histopathology 2021;78:148-61. [PMID: 33382497 DOI: 10.1111/his.14244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Eto K, Yoshida N, Iwagami S, Iwatsuki M, Baba H. Surgical treatment for gastrointestinal neuroendocrine tumors. Ann Gastroenterol Surg 2020;4:652-9. [PMID: 33319155 DOI: 10.1002/ags3.12396] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Ahmed M. Gastrointestinal neuroendocrine tumors in 2020. World J Gastrointest Oncol 2020; 12(8): 791-807 [PMID: 32879660 DOI: 10.4251/wjgo.v12.i8.791] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 39] [Article Influence: 23.0] [Reference Citation Analysis]
14 Wang R, Zheng-Pywell R, Chen HA, Bibb JA, Chen H, Rose JB. Management of Gastrointestinal Neuroendocrine Tumors. Clin Med Insights Endocrinol Diabetes. 2019;12:1179551419884058. [PMID: 31695546 DOI: 10.1177/1179551419884058] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
15 Erdem S, Troxler E, Warschkow R, Tsai C, Yerokun B, Schmied B, Stettler C, Blazer DG 3rd, Hartwig M, Worni M, Gloor B. Is There a Role for Surgery in Patients with Neuroendocrine Tumors of the Esophagus?Ann Surg Oncol. 2020;27:671-680. [PMID: 31605338 DOI: 10.1245/s10434-019-07847-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Alekberzade AV, Krylov NN, Garmanova TN, Shahbazov R, Azari F, Zuykova KS, Litovchenko ED. [Duodenal neuroendocrine tumors]. Khirurgiia (Mosk) 2019;:87-95. [PMID: 31355821 DOI: 10.17116/hirurgia201907187] [Reference Citation Analysis]
17 Dewan P, Bhat SP, Kishan Prasad HL, Ballal R, Sajitha K. Neuroendocrine Carcinoma of Duodenum-an Uncommon Tumour at an Unusual Site. Indian J Surg Oncol. 2019;10:199-203. [PMID: 30948899 DOI: 10.1007/s13193-018-0834-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]